Display options
Cite
Ram D, Patil S, Gowdappa B, et al. Atomoxetine Augmentation in a Case of Treatment Resistant Panic Disorder with Multiple Augments Failure: A Case Report. Clin Psychopharmacol Neurosci. 2015;13(3):321-3doi: 10.9758/cpn.2015.13.3.321.
Ram, D., Patil, S., Gowdappa, B., & Rajalakshmi, I. (2015). Atomoxetine Augmentation in a Case of Treatment Resistant Panic Disorder with Multiple Augments Failure: A Case Report. Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology, 13(3), 321-3. https://doi.org/10.9758/cpn.2015.13.3.321
Ram, Dushad, et al. "Atomoxetine Augmentation in a Case of Treatment Resistant Panic Disorder with Multiple Augments Failure: A Case Report." Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology vol. 13,3 (2015): 321-3. doi: https://doi.org/10.9758/cpn.2015.13.3.321
Ram D, Patil S, Gowdappa B, Rajalakshmi I. Atomoxetine Augmentation in a Case of Treatment Resistant Panic Disorder with Multiple Augments Failure: A Case Report. Clin Psychopharmacol Neurosci. 2015 Dec 31;13(3):321-3. doi: 10.9758/cpn.2015.13.3.321. PMID: 26598594; PMCID: PMC4662177.
Copy Download .nbib Format: NLM
Share it on

Clin Psychopharmacol Neurosci. 2015 Dec 31;13(3):321-3. doi: 10.9758/cpn.2015.13.3.321.

Atomoxetine Augmentation in a Case of Treatment Resistant Panic Disorder with Multiple Augments Failure: A Case Report.

Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology

Dushad Ram, Shwetha Patil, Basavana Gowdappa, Iyshwarya Rajalakshmi

Affiliations

  1. Department of Psychiatry, JSS Medical College, Mysore, India.
  2. Department of Medicine, JSS Medical College, Mysore, India.

PMID: 26598594 PMCID: PMC4662177 DOI: 10.9758/cpn.2015.13.3.321

Abstract

Atomoxetine, a selective norepinephrine inhibitor, is effective in comorbid anxiety and attention deficit hyperactivity disorder, however its role in panic disorder is unknown. We are presenting a case of panic disorder, who initially partially responded to clonazepam. When clonazepam was added with sertraline, escitalopram, desvenlafaxin, she did not improve significantly until paroxetine was added. When clonazepam-paroxetine combination was added with propranolol, etizolam, olanzepine, risperidone and amisulpride the symptom remission did not occur until a trial of Atomoxetine was done.

Keywords: Atomoxetine augment; Selective norepinephrine reuptake inhibitor; Treatment resistant panic disorder

References

  1. Auton Neurosci. 2010 Apr 19;154(1-2):48-53 - PubMed
  2. Arch Gen Psychiatry. 2006 Apr;63(4):415-24 - PubMed
  3. Neuropsychopharmacology. 2002 Nov;27(5):699-711 - PubMed
  4. Depress Anxiety. 2010 Feb;27(2):93-112 - PubMed
  5. J Clin Psychopharmacol. 2009 Dec;29(6):561-4 - PubMed
  6. Am Fam Physician. 2002 Oct 15;66(8):1477-84 - PubMed
  7. Rev Bras Psiquiatr. 2007 Oct;29 Suppl 2:S55-60 - PubMed
  8. Arch Gen Psychiatry. 1984 Aug;41(8):771-6 - PubMed
  9. Ann Clin Psychiatry. 2009 Apr-Jun;21(2):95-102 - PubMed
  10. Psychiatry (Edgmont). 2007 Oct;4(10):48-59 - PubMed
  11. J Am Acad Child Adolesc Psychiatry. 2007 Sep;46(9):1119-27 - PubMed
  12. Arch Gen Psychiatry. 1986 Nov;43(11):1042-54 - PubMed
  13. Pharmacotherapy. 2004 Aug;24(8):1020-36 - PubMed
  14. Naunyn Schmiedebergs Arch Pharmacol. 1995 Jun;351(6):624-9 - PubMed

Publication Types